Krane Funds Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,139
Closed -$393K 332
2021
Q3
$393K Sell
3,139
-1,281
-29% -$166K 0.01% 226
2021
Q2
$549K Buy
4,420
+716
+19% +$89.9K 0.02% 170
2021
Q1
$438K Buy
3,704
+607
+20% +$71.1K 0.02% 217
2020
Q4
$363K Buy
+3,097
New +$341K 0.01% 166
2020
Q1
Sell
-4,705
Closed -$534K 234
2019
Q4
$534K Sell
4,705
-145
-3% -$15.9K 0.03% 160
2019
Q3
$527K Buy
4,850
+4,589
+1,758% +$479K 0.04% 143
2019
Q2
$25K Buy
+261
New +$23.8K ﹤0.01% 167

Other funds holding MDT

Krane Funds Advisors's MDT Position: Q4 2021 in Review

Krane Funds Advisors sold out of Medtronic (MDT) in Q4 2021, closing a stake of 3,139 shares — an estimated $393K sold.

Krane Funds Advisors first reported a position in MDT in Q2 2019 and held it in 7 quarters. The position peaked at $549K in Q2 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Krane Funds Advisors reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Krane Funds Advisors sold 3,139 Medtronic shares in Q4 2021, an estimated $393K.
  • Krane Funds Advisors first reported a position in Medtronic in Q2 2019 and held it in 7 quarters.
  • Krane Funds Advisors's Medtronic position peaked at $549K in Q2 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Krane Funds Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.